Therapeutic Botulinum Toxin | Global | 2014 | Market Analysis
The global therapeutic BTX market will be grow robustly through 2022, with significant procedure and unit sales growth being driven by newly approved indications, the need for repeat BTX treatments, and a largely favorable reimbursement environment.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, France, Germany, Italy, Spain, the UK and Japan across a 10-year period.